Sentences with phrase «advancing gene and cell therapies»

ASGCT's vision is to serve as a catalyst to transform medicine by advancing gene and cell therapies to benefit patients and society.

Not exact matches

His research has spanned hematopoiesis, gene therapy, stem cell biology, genomics and cancer, consistently focusing on bringing the very latest research advances to patients with heretofore incurable diseases.
These include the ability to bring new, innovative products to the market; progress in oncology, such as the approval of Genentech's drug Avastin for breast cancer and advances in the use of gene therapy, despite some setbacks; continuing progress in research on stem cells; the emergence of treatments for previously untreated diseases; and solutions for food and fuel shortages, such as biocrops and biofuels.
For his part, Collins, who has led NIH since 2009 and been kept on by the Trump administration, pointed to an array of promising NIH activities, including the development of new technologies to provide insights into human brain circuitry and function through the Brain Research through Advancing Innovative Neuroethologies (BRAIN initiative) and the use of the gene - editing tool CRISPR - Cas9 to correct mutations and clear the way to develop and test a «curative therapy» for the first molecular disease: sickle cell disease.
The technical advances emerging from gene therapy have fueled the larger fields of cell and immune therapy, where DNA, immune molecules, and viruses are all elements to be manipulated, in concert or one at a time.
So for 17 patients with advanced melanoma who didn't have tumor - fighting T cells and had failed existing treatments, Rosenberg's team tried gene therapy.
He was awarded a European Research Council Advanced Investigator Grant (ERC) in 2009, the Outstanding Achievement Award from the American Society of Gene and Cell Therapy (ASGCT) in 2014 and from ESGCT in 2015, an Honorary doctorate from the Vrije University, Brussel, in 2015, the Jimenez Diaz Prize in 2016, and the Beutler Prize from the American Society of Hematology (ASH) in 2017.
His work also contributed to advance the use of artificial nucleases for targeted genome editing in cell and gene therapy.
Data from this trial was previously presented at World Advanced Therapies and Regenerative Medicine (May 17 - 19,2017; London, UK) and the 20th Annual Meeting American Society of Gene and Cell Therapy (ASGCT, May 10 - 13, 2017; DC, USA).
StemFit cell culture media has been independently evaluated by CGT Catapult, an independent centre of excellence helping advance the UK cell and gene therapy industry.
He is Professor of Cell and Gene Therapy in the Advanced Centre for Biochemical Engineering, University College London working on the clinical translation and commercialization of cell and gene therapCell and Gene Therapy in the Advanced Centre for Biochemical Engineering, University College London working on the clinical translation and commercialization of cell and gene therapGene Therapy in the Advanced Centre for Biochemical Engineering, University College London working on the clinical translation and commercialization of cell and gene therapcell and gene therapgene therapies.
The only plausible methods of repairing stochastic nuclear DNA damage look to be the aforementioned advanced molecular nanotechnology, something that lies some decades in the future, or major advances in gene therapy, to the point at which it could be cost - effective and safe to scan and conditionally alter the majority of genes in the majority of cells all at once.
Gene and cell therapies have made important medical advances over the past three decade, developing technologies and testing novel therapies in multiple human clinical trials of many diseases.
Important reports from the Weiner lab include the first DNA vaccine studied for HIV as well as for cancer immune therapy of cutaneous T cell lymphoma, the early development of DNA encoded genetic adjuvants, including IL - 12, advances in gene optimization, and advances in electroporation technologies resulting in improved gene delivery.
University of Pennsylvania immunotherapy researcher Dr. Carl June, who led the development of an experimental therapy for advanced childhood leukemia that is expected to become the first CAR T - cell therapy to win U.S. Food and Drug Administration approval, will give the keynote talk today at the Conference on Cell & Gene Therapy for HIV Cure at Fred Hutchinson Cancer Research therapy for advanced childhood leukemia that is expected to become the first CAR T - cell therapy to win U.S. Food and Drug Administration approval, will give the keynote talk today at the Conference on Cell & Gene Therapy for HIV Cure at Fred Hutchinson Cancer Research Cencell therapy to win U.S. Food and Drug Administration approval, will give the keynote talk today at the Conference on Cell & Gene Therapy for HIV Cure at Fred Hutchinson Cancer Research therapy to win U.S. Food and Drug Administration approval, will give the keynote talk today at the Conference on Cell & Gene Therapy for HIV Cure at Fred Hutchinson Cancer Research CenCell & Gene Therapy for HIV Cure at Fred Hutchinson Cancer Research Therapy for HIV Cure at Fred Hutchinson Cancer Research Center.
We made history in August 2017 when the FDA approved a personalized cell therapy for advanced leukemia, the first - ever for cancer cell and gene therapy.
Clinical and Regenerative medicine refers to development and implementation of advanced therapeutic approaches that may involve the support of expertise in gene / cell therapy, tissue engineering, pharmacology and pharmacogenomics, development of novel molecular target therapy.
a b c d e f g h i j k l m n o p q r s t u v w x y z